Cargando…
Power of the Dissolution Test in Distinguishing a Change in Dosage Form Critical Quality Attributes
For a dissolution method to be considered relevant to in vivo performance, the dissolution data profiles should show discrimination or meaningful change when there is a change in critical material attributes (CMAs) and critical product properties (CPPs). The dissolution test has been shown repeatedl...
Autor principal: | Gray, Vivian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848239/ https://www.ncbi.nlm.nih.gov/pubmed/30350251 http://dx.doi.org/10.1208/s12249-018-1197-7 |
Ejemplares similares
-
The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability
por: van der Merwe, Jannes, et al.
Publicado: (2020) -
FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms
por: Brown, Cynthia K., et al.
Publicado: (2011) -
Control of Drug Dissolution Rate from Film Dosage Forms Containing Valsartan
por: Murata, Yoshifumi, et al.
Publicado: (2016) -
Hot-Melt Extrusion Process Fluctuations and Their Impact on Critical Quality Attributes of Filaments and 3D-Printed Dosage Forms
por: Ponsar, Hanna, et al.
Publicado: (2020) -
The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms
por: Auel, Tobias, et al.
Publicado: (2021)